Arcturus Therapeutics

Arcturus Therapeutics News & Events

Arcturus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., as Chief Business Officer

October 28, 2013

FOR IMMEDIATE RELEASE SAN DIEGO, Calif., October 28, 2013 – Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of rare orphan diseases, today announced the expansion of its management team with the appointment of Zachary A. Zimmerman, Ph.D., as chief business officer. Dr. Zimmerman will be responsible for defining Arcturus’ corporate […]

Arcturus Therapeutics Raises $5 Million in Series A Funding to Maintain its Momentum in Nominating Lead Clinical Candidate in 2014

October 21, 2013

FOR IMMEDIATE RELEASE SAN DIEGO, Calif., October 21, 2013 – Arcturus Therapeutics, Inc., an industry leader in RNAi technologies for the treatment of rare orphan diseases, today announced it has secured $5 million in a Series A funding round led by multiple private capital, high net-worth investors from Canada, Japan and the United States. The […]